No information is available on the use of berdazimer gel during breastfeeding. Because it is a very large molecule, it is unlikely to be absorbed from the skin or pass into breastmilk. It is acceptable to use during breastfeeding, but avoid application to the nipple area and ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Berdazimer
CAS Registry Number
1846565-00-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Siloxanes
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
